bioRxivCancer BiologyPreprint
Deletion of Ferritin Heavy Chain Limits Tumor Growth and Promotes Iron-Dependent Stress in Medulloblastoma
Fabien Segui, Jérôme DurivaultiD, Marina PagnuzziiD, Valérie VialiD, Annael BerniniiD, Doria FilipponiiD, 武士 原山iD, Pauline PerneiD, Delphine DebayleiD, Kévin MülleriD, Eddy PasquieriD, Marion Le GrandiD, Scott K. ParksiD, Yann CormeraisiD, Jacques PouysséguriD, Milica VučetićiD, Vincent PiccoiD
- Citations
- 0
Abstract
Iron is essential for tumor proliferation and metabolic adaptation but becomes cytotoxic when unbuffered, creating a potential metabolic vulnerability. Ferritin, a conserved iron-storage complex, limits labile iron and establishes the upper threshold of iron tolerance in cancer cells. Here, we report the first ferritin heavy chain (FTH) knockout in a brain tumor model system. Although FTH loss was tolerated under basal conditions through adaptive remodeling of iron metabolism, it exposed profound vulnerabilities under iron stress. FTH deficiency lowered the threshold for iron toxicity, sensitizing medulloblastoma (MB) cells to both canonical ferroptosis and a mechanistically distinct iron-dependent cell death pathway. Oxidative iron stress impaired tumor growth and prolonged survival in orthotopic xenografts, whereas vitamin C-induced iron reduction triggered a selective, iron-dependent, but non-ferroptotic elimination of MB-like cells in tumor organoids. Notably, sensitivity to iron toxicity correlated strongly with cellular phenotype, with mesenchymal-like cells displaying greater susceptibility than epithelial-like counterparts. Collectively, these findings identify ferritin as a central regulator of iron tolerance in MB and establish iron toxicity, not via iron deprivation, as a therapeutically exploitable vulnerability. More broadly, this work provides a mechanistic framework for targeting iron metabolism through modulation of ferritin-dependent iron buffering and iron redox homeostasis in cancers. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/739635v1_ufig1.gif" ALT="Figure 1000"> View larger version (53K): org.highwire.dtl.DTLVardef@1c499a4org.highwire.dtl.DTLVardef@431c70org.highwire.dtl.DTLVardef@2b5borg.highwire.dtl.DTLVardef@11e9ac1_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: bulk RNA-seq
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: mechanistic / dynamical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MMRi62 induces iron depletion-driven apoptosis through a ferritin-independent mechanism
Fabien Segui, Marina Pagnuzzi, … Vincent Picco·bioRxiv·Sep 23, 2026
- Tumor cell-intrinsic HFE drives glioblastoma growth
K. M. Troike, D. J. Silver, … J. Lathia·bioRxiv·Apr 13, 2022
- Repressing ABCB7 Potentiates Cisplatin Response in Pediatric Group 3 Medulloblastoma by Triggering Ferroptosis
R. K. Kanchan, N. Perumal, … S. Mahapatra·bioRxiv·Jan 24, 2022
- Methionine stress induces a ferroptotic gene signature in methionine dependent cancer cells
K. F. Wallis, J. T. Bird, … I. R. Miousse·bioRxiv·Aug 18, 2020
- Tumor-associated macrophages protect glioblastoma cells from ferroptosis by inducing the release of ferritin-bound iron via exosomes.
Swetapadma Sahu, Kondaiah Palsa, … James R. Connor·Journal of Neuro-OncologyPeer-reviewed·Apr 1, 2026
- Ferrous Iron Accumulation Is a Hallmark and Therapeutic Vulnerability of Therapy-Induced Senescence
Zhiming Wang, Yuanhui Liu, … Yulin Li·bioRxiv·May 23, 2026